Notice of Participation of the National Institute on Aging (NIA) in PA-18-871 BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed)

Notice Number: NOT-AG-20-016

Key Dates
Release Date: January 31, 2020

Related Announcements
PA-18-871

Issued by

National Institute on Aging (NIA)


Purpose

This Notice informs potential applicants that the National Institute on Aging (NIA) is participating, effective immediately, in PA-18-871 BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed).

The following text has been added to reflect NIA's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Aging (NIA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.866

Scientific/Research Contact(s)
Michael-David A.R.R, Kerns, M.M., M.S., Ph.D.
National Institute on Aging (NIA)
Email: kernsmd@mail.nih.gov

Financial/Grants Management Contact(s)
Robin Laney
National Institute on Aging (NIA)
Telephone: 301-496-1472
Email: laneyr@mail.nih.gov

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Michael-David A.R.R. Kerns, M.M., M.S., Ph.D.
National Institute on Aging (NIA)
Email: kernsmd@mail.nih.gov